DOI 10.1016/j.vaccine.2025.127945
Provider setting for influenza and COVID-19 vaccination among Australian adults in 2023 and 2024.
Аннотация
OBJECTIVES
Australia expanded access to funded pharmacy vaccination in 2024. We examined changes in the proportion of adult pharmacy-administered vaccination.
METHODS
Adult influenza and COVID-19 vaccinations reported in the Australian Immunisation Register from 2023 to 2024 linked to Australian Census socio-demographic information were assessed.
RESULTS
In 2023, 61% of 7.49 million influenza and 54% of 4.61 million COVID-19 vaccinations were provided in general practices, compared to 24% and 44%, respectively, in pharmacies. While total vaccinations declined in 2024 (influenza: 7.04 million; COVID-19: 2.48 million) there was a small increase in pharmacy-administered influenza vaccinations (adjusted odds ratio 1.16 95%CI 1.16-1.17). In both years, a lower proportion of pharmacy-administered vaccinations were given to adults: aged ≥65 years (vs. <65 years); from culturally and linguistically diverse(CALD) backgrounds (vs. non-CALD); with lower incomes, employment and education (vs. higher).
CONCLUSION
Expanding pharmacy provision of vaccinations may improve uptake, but understanding the impact on under-vaccinated populations is needed.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.